It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Recent developments in stem cell biology have enabled the study of cell fate decisions in early human development that are impossible to study in vivo. However, understanding how development varies across individuals and, in particular, the influence of common genetic variants during this process has not been characterised. Here, we exploit human iPS cell lines from 125 donors, a pooled experimental design, and single-cell RNA-sequencing to study population variation of endoderm differentiation. We identify molecular markers that are predictive of differentiation efficiency of individual lines, and utilise heterogeneity in the genetic background across individuals to map hundreds of expression quantitative trait loci that influence expression dynamically during differentiation and across cellular contexts.
Studying the genetic effects on early stages of human development is challenging due to a scarcity of biological material. Here, the authors utilise induced pluripotent stem cells from 125 donors to track gene expression changes and expression quantitative trait loci at single cell resolution during in vitro endoderm differentiation.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details







1 European Bioinformatics Institute, Wellcome Genome Campus, CB10 1SD Hinxton, European Molecular Biology Laboratory, Cambridge, UK (GRID:grid.225360.0) (ISNI:0000 0000 9709 7726)
2 European Bioinformatics Institute, Wellcome Genome Campus, CB10 1SD Hinxton, European Molecular Biology Laboratory, Cambridge, UK (GRID:grid.225360.0) (ISNI:0000 0000 9709 7726); St Vincent’s Institute of Medical Research, Fitzroy, Australia (GRID:grid.1073.5) (ISNI:0000 0004 0626 201X)
3 Wellcome Genome Campus, Wellcome Sanger Institute, Hinxton, UK (GRID:grid.1073.5)
4 European Bioinformatics Institute, Wellcome Genome Campus, CB10 1SD Hinxton, European Molecular Biology Laboratory, Cambridge, UK (GRID:grid.225360.0) (ISNI:0000 0000 9709 7726); Wellcome Genome Campus, Wellcome Sanger Institute, Hinxton, UK (GRID:grid.225360.0)
5 Wellcome Genome Campus, Wellcome Sanger Institute, Hinxton, UK (GRID:grid.225360.0)
6 Wellcome Genome Campus, Wellcome Sanger Institute, Hinxton, UK (GRID:grid.225360.0); Anne McLaren Laboratory, University of Cambridge, Wellcome Trust—MRC Cambridge Stem Cell Institute, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934); University of Cambridge, Department of Surgery, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934); University of Cambridge, Department of Haematology, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934); GeneLab, AWG Multi-Omics/System Biology, NASA Ames Research Center, California, USA (GRID:grid.419075.e) (ISNI:0000 0001 1955 7990)
7 Wellcome Genome Campus, Wellcome Sanger Institute, Hinxton, UK (GRID:grid.419075.e)
8 Wellcome Genome Campus, Wellcome Sanger Institute, Hinxton, UK (GRID:grid.225360.0); Functional Genomics and Metabolism Unit, University of Southern Denmark, Danish Institute of Advanced Study (D-IAS), Odense, Denmark (GRID:grid.10825.3e) (ISNI:0000 0001 0728 0170)
9 Wellcome Genome Campus, Wellcome Sanger Institute, Hinxton, UK (GRID:grid.10825.3e)
10 King’s College London, Strand Ln, London, United Kingdom (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764)
11 University of Cambridge and National Health Service Blood and Transplant, Department of Haematology, Cambridge, United Kingdom (GRID:grid.5335.0) (ISNI:0000000121885934)
12 University of Dundee, Centre for Gene Regulation and Expression, School of Life Sciences, Dundee, United Kingdom (GRID:grid.8241.f) (ISNI:0000 0004 0397 2876)
13 University College London, Gower St, Bloomsbury, London, United Kingdom (GRID:grid.83440.3b) (ISNI:0000000121901201)
14 Wellcome Genome Campus, Wellcome Sanger Institute, Hinxton, UK (GRID:grid.83440.3b); Anne McLaren Laboratory, University of Cambridge, Wellcome Trust—MRC Cambridge Stem Cell Institute, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934); University of Cambridge, Department of Surgery, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934)
15 European Bioinformatics Institute, Wellcome Genome Campus, CB10 1SD Hinxton, European Molecular Biology Laboratory, Cambridge, UK (GRID:grid.225360.0) (ISNI:0000 0000 9709 7726); Wellcome Genome Campus, Wellcome Sanger Institute, Hinxton, UK (GRID:grid.225360.0); University of Cambridge, Cancer Research UK Cambridge Institute, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934)
16 Wellcome Genome Campus, Wellcome Sanger Institute, Hinxton, UK (GRID:grid.5335.0)
17 European Bioinformatics Institute, Wellcome Genome Campus, CB10 1SD Hinxton, European Molecular Biology Laboratory, Cambridge, UK (GRID:grid.225360.0) (ISNI:0000 0000 9709 7726); German Cancer Research Center (DKFZ), Division of Computational Genomics and Systems Genetics, Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584); Genome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany (GRID:grid.4709.a) (ISNI:0000 0004 0495 846X)